文献速递区域麻醉与超声术前评估与围术期医学

麻醉方式与非肌层浸润性膀胱癌2年复发率:一项随机临床试验

Anesthetic approaches and 2-year recurrence rates in non-muscle invasive bladder cancer: a randomized clinical trial.
PubMed 文献 · Reg Anesth Pain Med · 2026-04-02

该前瞻性随机对照试验在首尔大学医院纳入287例临床NMIBC患者,比较脊髓麻醉与全身麻醉下经尿道膀胱肿瘤电切术后的肿瘤学结局。时间事件分析显示脊髓麻醉组2年复发率显著低于全麻组,疾病进展在全麻组更常见但差异无统计学意义。提示脊髓麻醉或可作为首选麻醉方式。

要点

  • 脊髓麻醉组2年NMIBC复发率显著低于全麻组。
  • 全麻组疾病进展发生率高于脊髓麻醉组,但差异无统计学意义。
  • 脊髓麻醉或可考虑作为NMIBC电切术的首选麻醉方式。

核心结论

  • 脊髓麻醉与全麻相比,NMIBC患者术后2年复发率显著降低。
  • 脊髓麻醉或可考虑作为NMIBC经尿道电切术的首选麻醉方式。

研究设计与样本

  • 前瞻性随机对照试验,2018至2020年在首尔大学医院招募287例临床NMIBC患者。
  • 患者随机分组后4周内行经尿道膀胱肿瘤电切术,比较脊髓麻醉与全身麻醉。
  • 主要结局为切除术后2年疾病复发,次要结局为疾病进展,采用时间事件分析比较累积发生率。

主要发现

  • 意向治疗分析中,脊髓麻醉组2年复发率为27.4%,全麻组为39.8%。
  • 改良意向治疗人群中,脊髓麻醉组2年复发率为26.8%,全麻组为39.6%。
  • 疾病进展在全麻组发生率15.2%,脊髓麻醉组7.8%,差异无统计学意义。
  • 15例因临床需要(如脊髓麻醉失败或明显闭孔反射)改用其他麻醉,改良意向治疗人群为272例。

关键数值与推荐

  • 脊髓麻醉组鞘内注射0.5%高比重布比卡因。
  • 全麻组以丙泊酚1-2 mg/kg与芬太尼50-100 μg/kg混合诱导。
  • 全麻维持使用地氟烷或七氟烷。

临床怎么用

  • 对于拟行经尿道膀胱肿瘤电切术的NMIBC患者,可优先考虑脊髓麻醉以降低2年复发率。
  • 需注意脊髓麻醉失败或明显闭孔反射时可能需改用其他麻醉方式。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The effect of anesthesia methods on non-muscle invasive bladder cancer (NMIBC) recurrence post-resection remains uncertain. We aimed to compare the oncological outcomes of spinal anesthesia (SA) and general anesthesia (GA) in patients with NMIBC. METHODS: This prospective randomized controlled trial recruited 287 patients with clinical NMIBC at Seoul National University Hospital from 2018 to 2020. The patients underwent transurethral resection of the bladder tumor within 4 weeks of randomization. Intrathecal hyperbaric bupivacaine (0.5%) and a mixture of propofol (1-2 mg/kg) and fentanyl (50-100 μg/kg) were used as induction agents in the SA and GA groups, respectively, with desflurane or sevoflurane used for maintaining anesthesia. The primary and secondary outcome measures were disease recurrence and disease progression, respectively, at 2 years after resection. Cumulative incidence of outcomes was compared between the two groups using time-to-event analyses. RESULTS: 15 patients required alternative anesthesia owing to clinical needs such as SA failure or significant obturator reflex, resulting in a modified intention-to-treat (ITT) population of 272 patients. Time-to-event analysis showed a significantly lower recurrence of NMIBC in the SA group than in the GA group, in both ITT (27.4% vs 39.8%) and modified ITT populations (26.8% vs 39.6%). Disease progression occurred more frequently in the GA than in the SA group (15.2% vs 7.8%), although the difference was not statistically significant. CONCLUSIONS: A notable reduction in the 2-year recurrence rate was observed in patients who underwent SA than in those who underwent GA. Thus, SA may be considered the preferred anesthetic approach. TRIAL REGISTRATION NUMBER: NCT03597087.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Han JH, Yuk HD, Jeong SH, et al. Anesthetic approaches and 2-year recurrence rates in non-muscle invasive bladder cancer: a randomized clinical trial. Reg Anesth Pain Med. 2026. PMID: 39740955. doi:10.1136/rapm-2024-105949

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。